Part,  Chapter, Paragraph

 1   II,     5.  2.  4   |   alongside the three already mentioned most important risk factors
 2   II,     5.  4.  6   |      one or more of the above mentioned risk factors. This is one
 3   II,     5.  5.  3   |       at 50 to 59. As already mentioned above, mortality data seem
 4   II,     5.  5.  3   |      history. These disorders mentioned above are now conceptualised
 5   II,     5.  5.  3   |  likely to occur as MS is not mentioned (Ford et al, 2002).~MS is
 6   II,     5.  7.  3   |      adolescence in the above mentioned population-based registry
 7   II,     5.  8.  3   |  cause of death when COPD was mentioned as an associated cause on
 8   II,     7.  1       |   already had underpinned the mentioned policy documents. Figures
 9   II,     7.  3.  0(1)|       fact sheet based on the mentioned report serves as the Executive
10   II,     7.  5       | guideline by the WHO is to be mentioned: “Injury Surveillance Guidelines”
11   II,     9.  1.  2   |   syndrome and, as previously mentioned, the completeness of ascertainment
12   II,     9.  3.  3   |      from the age group 18-69 mentioned that they had always or
13  III,    10.  2.  1(9)|   that these and other herein mentioned estimates are far from robust
14  III,    10.  2.  1   |         More than one drug is mentioned in 60-90% of all death cases
15  III,    10.  2.  1   |       and evaluation are also mentioned as key activities for a
16  III,    10.  2.  1   |     Poly-drug use, as already mentioned, risk behaviours among drug
17  III,    10.  2.  1   |       vitamin D as previously mentioned. Deficiencies can lay the
18  III,    10.  2.  5   |   Moreover, it should also be mentioned that the human body and
19  III,    10.  3.  4   |   some aspects can be briefly mentioned in this chapter. With regard
20  III,    10.  4.  2   |       the spread of the above mentioned diseases.~ ~The same Directive
21  III,    10.  4.  2   |     substances not explicitly mentioned(a very large number of substances).~ ~
22  III,    10.  5.  3   | affected, the five most often mentioned health problems were backache,
23  III,    10.  5.  3   |  Member States, where the two mentioned conditions represent 39%
24  III,    10.  6.  2   |    EURO.~ ~Local level~Having mentioned activities at European and
25   IV,    11.  3.  2   |      of reference pricing (as mentioned above). Policies to promote
26   IV,    12. 10       | ALEXANDROS~ It should be also mentioned that a Steering Committee
27   IV,    12. 10       |     in this bag all the above mentioned packaging empty and clean.
28   IV,    12. 10       |     compliance with the above mentioned regulations~ ~Extreme weather
29   IV,    12. 10       |       public health politics, mentioned by the European Union and